The Lancet Oncology in conversation with

The Lancet Oncology in conversation with

Release Date

All Episodes

Dylan Graetz and Erica Kaye on qualitative research in oncology

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Dylan Graetz (Department of Oncology and Department of Global Pediatric Medicine, St Jude Children’s Research Hospital) and Dr Erica Kaye (Department of Oncology, St Jude Children’s Research Hospital) to discuss ...  Show more

Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers

Cheryl Lai, Senior Editor of The Lancet Oncology, is joined by Dr Jesse Plascak (Division of Cancer Prevention and Control, The Ohio State University) and Dr Marissa Baker (Department of Environmental & Occupational Health Science, University of Washington School of Public Health ...  Show more

Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3

Dr Andre Pfob (Department of Obstetrics & Gynecology, Heidelberg University Hospital) and Prof Peter Dubsky (Faculty of Health Sciences and Medicine, University of Lucerne) discuss their Review entitled The Lucerne Toolbox 3: digital health and artificial intelligence to o ...

  Show more

Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission

Dr Gary Rodin discusses The human crisis in cancer: a Lancet Oncology Commission which identifies a growing imbalance between technological innovation and the human dimensions of cancer care.

Click here to read the full Commission: <a href='https://www.thelancet ...

  Show more

Matthias Preusser on the phase 2 TUXEDO-3 trial

Deputy Editor Ali Landman speaks with Matthias Preusser (Medical University of Vienna, Vienna, Austria) about two reports from the phase 2 TUXEDO-3 trial investigating patritumab deruxtecan (HER3-Dxd) in patients with active brain metastases of breast cancer or non-small-cell ...

  Show more